Metrodora Institute operated a multidisciplinary clinic that combined neurology, psychiatry, pain management, and research to provide coordinated care for patients with complex, chronic neurological and neuropsychiatric conditions. By embedding clinical visits within translational research protocols, the institute offered access to advanced diagnostics and experimental therapies while feeding real‑world outcomes back into scientific studies. Although the clinic has closed, it continues to support former patients with records requests, billing assistance, and research inquiry channels.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with complex, chronic neurological and neuropsychiatric conditions often struggle to find coordinated care that combines clinical treatment with cutting‑edge research, leading to fragmented services and limited access to novel therapies.
Solution
Metrodora Institute was established as a multidisciplinary clinic that integrates patient care with translational research. The institute brings together neurologists, psychiatrists, pain specialists, and researchers in a single setting to develop and test new diagnostic tools and therapeutic approaches. By embedding research protocols within routine visits, Metrodora enables rapid feedback loops between clinical observations and scientific discovery. Although the clinic has now closed, the organization continues to support former patients through a dedicated records‑request service, billing assistance, and a channel for research inquiries.
Target Audience
Primary users were individuals with rare or treatment‑resistant neurological and neuropsychiatric disorders, as well as academic and industry researchers seeking access to well‑characterized patient cohorts.
Features
- Multidisciplinary team of neurologists, psychiatrists, pain specialists, and researchers collaborating on patient cases
- Integrated clinical‑research workflow that enrolls patients in ongoing studies during standard appointments
- Access to advanced diagnostic technologies and experimental therapies not widely available in typical practice settings
- Structured data collection platform that feeds real‑world patient outcomes back into research pipelines
- Post‑closure support infrastructure for medical records, billing questions, and research contact points